Proactive Investors - Run By Investors For Investors

Breakfast News - Salt Lake Potash, Mobile Streams & Flowgroup.

Breakfast News - Salt Lake Potash, Mobile Streams & Flowgroup.

Set menu


Total number of AIM Companies (Incl Susp):




Total number of AIM Companies trading:




*as at close of business  08 November 2018


Standard List**  of Main Market:


Total number of Standard List Companies


(Incl Susp):




Total number of Standard List Companies trading:




*as at close of business 08 November 2018


NEX Growth Market:


Total number of NEX Growth Market Companies (Incl Susp):




Total number of NEX Growth Market Companies trading:




*as at close of business 08 November 2018


*A corporate client of Hybridan LLP


**  Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity


Dish of the day


No Joiners Today


Off the menu      


TyraTech has left AIM after being acquired by American Vanguard Corporation at 3.15p


Banquet Buffet


Salt Lake Potash (LON:SO4) 24.5p £43.76m


Salt Lake Potash is  announced that it has received strong commitments from both existing and new institutional and sophisticated investors in Australia and overseas to subscribe for 31.0 million new ordinary shares of the Company, to raise gross proceeds of $13m. There was very strong demand for the Placement, an endorsement of the recent appointment of Tony Swiericzuk as CEO and also of the Company's world class Sulphate of Potash project.


Proceeds from the Placement will be used to fund construction of the Williamson Ponds and dewatering of the Williamson Pit, as well as ongoing development of on-lake infrastructure, exploration and feasibility studies, and general working capital.


Directors and senior management intend to subscribe for a total of 2.4 million shares in the Placement, including 952,381 shares by the CEO, Mr Tony Swiericzuk, and 750,000 shares by the Company's Chairman, Mr Ian Middlemas, which will be issued subject to shareholder approval.


The issue price of A$0.42 represents a 13.4% discount to the last closing price of $0.485 on ASX.


Fastjet (LON:FJET) 1.65p £10.86m


fastjet, the low-cost African airline, is providing a further update in relation to its current cash position and discussions regarding additional funding, following the announcement on 31 Oct 2018 which noted that additional funding would be required and if the Company is unable to carry out an equity fundraise and/or reach an agreement with its key creditors in the coming days, the Group would be unable to continue trading as a going concern.


The Company continues to review its current cash requirements and is able to continue operating during Nov due to some improvement in trading, cash generation and internal efficiencies. The headroom available allows the Company further time to continue discussions with its major shareholders and creditors.


As previously announced, in conjunction with fundraising discussions, the Company has been negotiating with key creditors of the Group to reduce the outstanding balances due to be paid and reduce the burden of interest and capital repayments. This process has been constructive but remains ongoing.


As at 7 Nov 2018, the Group had cash balances of US$ 3.9m, of which US$ 3m is restricted cash held inside Zimbabwe.


Empyrean Energy  (LON:EME) 10.45p £40.36m


Empyrean Energy, the oil and gas development company with interests in China, Indonesia and the United States, announced that Gaffney, Cline & Associates ("GCA"), an independent petroleum advisory firm, has completed its independent audit of the Company's oil initially in place estimates over the Jade, Topaz and Pearl prospects identified in Block 29/11, Pearl River Mouth Basin, offshore China, in which the Company has a 100% working interest (the "STOIIP  Audit") .


Total Mean Oil in-place increased 9% to 884 MMbbl from 814 MMbbl on an un-risked basis


GCA's estimates of Geological Chance of Success of Jade and Topaz prospects is 32% and 30% respectively


The independent assessment validates the Company's internal estimates announced in June 2018


The total P10 estimates increased 47% to 1588 MMbbl from 1081 MMbbl on an un-risked basis


Premier African Minerals (LON:PREM) 0.16p £11.58m


Premier African Minerals announced that the Board has reached an agreement to amend the terms of the existing loan agreement entered with a company owned by a Trust of which George Roach is a beneficiary for gross value of $300,000 as announced on 5 June 2018.


The initial maturity of 60 days was extended until 30 Nove 2018 as announced on 27 June 2018. The Loan is secured against the Company's shareholding of 6,128,822 shares in ARC Minerals Limited and the Company had agreed to underwrite any reasonable shortfall following the sale of the shares, should this be necessary. At the last closing Arc's market price of 3.55p, the value of the Security was approximately £0.217m.


The lenders have now agreed to cancel the Security in return for the grant of conversion rights with respect to the entire Loan amount. The Company has agreed therefore that the Loan can be converted into new ordinary shares at any time on or before the maturity date at the lesser of the Volume Weight Average Price for the five trading days immediately prior to the date of conversion or the closing price of the Premier's shares on the day preceding this announcement.


Mobile Streams (LON:MOS) 0.72p £0.93m


Mobile Streams, the emerging markets focused mobile media company, announces its final audited results for the year ended 30 June 2018.


Decrease in revenues to £3m (2017: £5.7m) caused primarily by ongoing challenges in the Company's core market of Argentina.


EBITDA loss of £1.2m (2017 loss: £1.48m) attributable to expansion in India.


Loss before tax £0.9m (2017 loss: £1.5m)


Loss after tax of £1m (2017 loss of £1.7m)


Basic loss per share of 1p per share (2017: loss of 2.62p per share)


£1m in cash (2017: £2.3m), with no debt. Current cash is £0.7m


Agreements signed with all 4 of the mobile carriers in India, with an addressable audience of over 1 billion mobile users


Revenue and margin have stabilized, globally, in the second half of the financial year, despite currency depreciation in Argentina and India.


Launch of a 3rd store in India, featuring premium HTML5 games, to enable additional payment mechanisms and mobile device market.


Haydale (LON:HAYD) 18.5p £6.42m


Haydale, the global advanced materials group, announced the following update in respect of its current financial position.


The Group's planned $1.5m investment project in its new Silicon Carbide cutting tools production line remains on track, with newly acquired tooling and equipment being assembled in the Group's US facility in South Carolina on budget and within the timetable. The Group anticipates first revenues from these products to commence in Spring 2019 and to lead to HCT being EBITDA positive thereafter.


As previously stated, it has been the Group's intention to refinance the capital equipment purchased by the Group for HCT's new cutting tools production line. Following discussions with possible lenders, which are ongoing, the Group now believes that such funding will not be available until production commences. As a consequence, the Group will be seeking alternative sources of finance in the coming months to satisfy its ongoing financial obligations in the short to medium term to support the Group as its technology moves into commercial adoption. A further update on financing will be made in due course.


Gordon Dadds Group (LON:GOR) SUSPENDED


Further to our announcement of 29 Oct 2018, the Board of Gordon Dadds Group, the fast-growing professional services consolidator, confirms that negotiations regarding the acquisition of the international network of law firms, Ince & Co International LLP and its affiliated entities, continue along with associated legal and financial due diligence.


Gordon Dadds' acquisition of Ince & Co International LLP and its affiliated entities, as publicly announced, would be classified as a reverse takeover under Rule 14 of the Aim Rules for Companies. While discussions continue, trading in Gordon Dadds' ordinary shares will remain suspended pending final conclusion of these discussions. A further announcement will be made in due course.


Futura Medical (LON:FUM) 6.65p £8.05m


Futura Medical, a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, announced that it will be presenting data on its DermaSys® drug delivery technology and lead product MED20051, a topical glyceryl trinitrate gel for the treatment of erectile dysfunction ("ED"), at the 19th Annual Fall Scientific Meeting of SMSNA, on 8-11 November 2018 at the Loews Miami Beach Hotel, Miami, Florida USA.


Tim Holland, Director of Clinical Development at Futura Medical, will give an oral presentation (#155) entitled "Pharmacokinetics (PK) of MED2005, a Topical Glyceryl Trinitrate Gel for the Treatment of Erectile Dysfunction2" on Friday 9 November at 16:25 EST. The presentation will be part of the 'Erectile Dysfunction (Medical) - Moderated Posters' session.


Sutton Harbour (LON:SUH) 31p £32.21m


The Company is pleased to announce that, following the meeting of the Planning Committee of Plymouth City Council held on 8 November 2018, the application for the mixed use residential and commercial building at Sugar Quay received unanimous approval. Additionally, the application for the related expansion and improvement of Harbour Car Park gained the committee's support. The Company continues to work towards the successful delivery of these development schemes along with the residential building at the Harbour Arch Quay.




Flowgroup sold its principal subsidiary Flow Energy Limited on 1 May 2018. Since that time, the Company has explored the possibility of a reverse takeover but has been unable to identify any viable opportunities.


The board has today appointed Geoff Rowley and Philip Armstrong of FRP Advisory LLP as joint administrators of the Company.


Cenkos Securities plc, the Company's nominated adviser, has resigned with immediate effect.


Trading in the Company's shares is currently suspended.


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use